Camtek (NASDAQ:CAMT) Bolsa

Camtek

Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.

Stifel analyst Brian Chin maintains Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) with a Buy and raises the price target from $84 to $98.

News

Price Target

Analyst Ratings

CAMT

Stifel Maintains Buy on Camtek, Raises Price Target to $98

WIIM

Camtek shares are trading higher after Oppenheimer initiated coverage with an Outperform rating and announced a price target of $100.

Oppenheimer analyst Edward Yang initiates coverage on Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) with a Outperform rating and announces Price Target of $100.

Initiation

Oppenheimer Initiates Coverage On Camtek with Outperform Rating, Announces Price Target of $100

Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Camtek and provided 12-month price targets. The average target is $83.86, accompanied by a high estimate of $95.00 and a low estimate of $80.00. Experiencing a 17.32% decline, the current average is now lower than the previous average price target of $101.43. 
<img src="https://www.benzinga.com/files/images/story/2025/1750770049_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A comprehensive examination of how financial experts perceive Camtek is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Prisco</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Craig Ellis</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$95.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Mark Lipacis</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$82.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Charles Shi</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$80.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$85.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$80.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Blayne Curtis</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$85.00</td>
<td>$120.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Camtek. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Camtek compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Camtek's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Camtek's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CAMT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Camtek analyst ratings.</a>
<h2>Get to Know Camtek Better</h2>
Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.
<h3>Camtek: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Over the 3M period, Camtek showcased positive performance, achieving a revenue growth rate of 22.29% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Camtek's net margin excels beyond industry benchmarks, reaching 28.92%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 6.03%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Camtek's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 3.76%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.34, Camtek adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Camtek: 7 Analysts Share Their Views

Cantor Fitzgerald analyst Matthew Prisco maintains Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) with a Neutral and raises the price target from $70 to $80.

Cantor Fitzgerald Maintains Neutral on Camtek, Raises Price Target to $80

B. Riley Securities analyst Craig Ellis maintains Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) with a Buy and raises the price target from $85 to $95.

B. Riley Securities Maintains Buy on Camtek, Raises Price Target to $95

Evercore ISI Group analyst Mark Lipacis maintains Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) with a Outperform and lowers the price target from $100 to $82.

Evercore ISI Group Maintains Outperform on Camtek, Lowers Price Target to $82

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>HC Wainwright &amp; Co. cut Annexon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANNX#NASDAQ">ANNX</a>) price target from $20 to $14. HC Wainwright &amp; Co. analyst Andrew Fein maintained a Buy rating. Annexon shares closed at $1.75 on Tuesday. <a href="https://www.benzinga.com/quote/ANNX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Telsey Advisory Group cut the price target for V.F. Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) from $27 to $17. Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating. V.F. Corporation shares closed at $14.95 on Tuesday. <a href="https://www.benzinga.com/quote/VFC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Rosenblatt boosted Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) price target from $260 to $300. Rosenblatt analyst Chris Brendler maintained a Buy rating. Coinbase shares closed at $256.90 on Tuesday. <a href="https://www.benzinga.com/quote/COIN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>TD Securities raised the price target for Wingstop Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) from $310 to $330. TD Securities analyst Andrew Charles maintained a Buy rating. Wingstop shares closed at $286.30 on Tuesday. <a href="https://www.benzinga.com/quote/WING/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies increased the price target for Danaos Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAC#NYSE">DAC</a>) from $100 to $105. Jefferies analyst Omar Nokta maintained a Buy rating. Danaos shares closed at $88.80 on Tuesday. See how other analysts <a href="https://www.benzinga.com/quote/DAC/analyst-ratings">view this stock</a>.</li>
<li>Needham cut Camtek Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) price target from $110 to $80. Needham analyst Charles Shi maintained a Buy rating. Camtek shares settled at $68.61 on Tuesday. <a href="https://www.benzinga.com/quote/CAMT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham increased On Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) price target from $55 to $62. Needham analyst Tom Nikic maintained a Buy rating. On Holding shares closed at $57.38 on Tuesday. <a href="https://www.benzinga.com/quote/ONON/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Chardan Capital cut MeiraGTx Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGTX#NASDAQ">MGTX</a>) price target from $38 to $35. Chardan Capital analyst Daniil Gataulin maintained a Buy rating. MeiraGTx shares closed at $5.15 on Tuesday.  <a href="https://www.benzinga.com/quote/MGTX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies increased the price target for PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) from $70 to $105. Jefferies analyst Ashley Helgans upgraded the stock from Hold to Buy. PVH shares settled at $80.50 on Tuesday. <a href="https://www.benzinga.com/quote/PVH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Leerink Partners slashed iTeos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) price target from $47 to $9. Leerink Partners analyst Daina Graybosch downgraded the stock from Outperform to Market Perform. iTeos Therapeutics shares closed at $7.85 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying COIN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="589" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14074708/image-159-1024x589.png" alt="" class="wp-image-914848" style="width:567px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14074708/image-159-1024x589.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14074708/image-159-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14074708/image-159-768x442.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14074708/image-159.png 1118w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Trading Ideas

ANNX

COIN

ITOS

MGTX

NGNE

ONON

WING

Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday

Needham analyst Charles Shi maintains Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) with a Buy and lowers the price target from $110 to $80.

Needham Maintains Buy on Camtek, Lowers Price Target to $80

Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) sees Q2 sales of $120.000 million-$123.000 million vs $119.01 million analyst estimate.

Guidance

Camtek Sees Q2 Sales $120.000M-$123.000M vs $119.01M Est

Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.77 by 2.6 percent. This is a 23.44 percent increase over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $118.60 million which missed the analyst consensus estimate of $119.28 million by 0.57 percent. This is a 22.14 percent increase over sales of $97.10 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Camtek Q1 Adj. EPS $0.79 Beats $0.77 Estimate, Sales $118.60M Miss $119.28M Estimate

ABOS

ABSI

ACCS

ACHV

ACXP

ADAP

ALCO

ALLO

ASNS

AUID

AVXL

BDSX

BEAT

BKTI

BWAY

BWEN

CAPR

CINT

CLPT

CLRB

CNCK

CYBR

DARE

DLPN

DMAC

ELMD

ETON

EXEL

FENC

FLOC

FTHM

GAIN

GAUZ

GENK

GEVO

GNSS

GOCO

GRAL

GUTS

HSON

HUMA

HUYA

HYFM

HYLN

HYPR

ICMB

IMOS

INLX

IRIX

ITRM

IZEA

KOPN

KRMN

LCTX

LEGN

LOAR

LSTR

LUNR

LXRX

MASS

MBRX

MCHX

MDAI

MGNX

MPTI

NMTC

NPCE

NUTX

NUWE

NXGL

NYAX

OKLO

OPXS

PERI

PRTS

PSFE

PXLW

Earnings Scheduled For May 13, 2025

Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) is preparing to release its quarterly earnings on Tuesday, 2025-05-13. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Camtek to report an earnings per share (EPS) of $0.77.
The market awaits Camtek's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Past Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.02, leading to a 1.62% increase in the share price the following trading session.
Here's a look at Camtek's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.75</td>
<td>0.69</td>
<td>0.64</td>
<td>0.57</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.77</td>
<td>0.75</td>
<td>0.66</td>
<td>0.64</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>-6.0%</td>
<td>-9.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747058507_0.png" alt="eps graph" />
<h3>Market Performance of Camtek's Stock</h3>
Shares of Camtek were trading at $66.57 as of May 09. Over the last 52-week period, shares are down 25.74%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/CAMT/earnings">To track all earnings releases for Camtek visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

An Overview of Camtek's Earnings

AAOI

ACMR

AEVA

ALAB

ALGM

ANET

AOSL

CEVA

CIEN

COHR

COMM

CRDO

CRSR

DELL

DOCN

ENTG

FARO

FLEX

FORM

GDDY

GLOB

ICHR

LDTC

LITE

LOGI

LRCX

LSCC

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MKSI

MOVE

MTSI

NTAP

NVDA

NVMI

NXPI

OKTA

ONTO

PRSO

PSTG

RGTI

RMBS

SELX

SHOP

SITM

SMTC

SNOW

SYNA

TSSI

TWLO

UCTT

VNET

ZBRA

Shares of companies within the broader technology sector are trading higher amid overall market strength after President Trump said he had no intention of firing Fed Chair Powell. Additionally, Trump indicated the final tariff rate would be less than the current 145% but not 0%.

Barclays analyst Tom O'Malley maintains Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) with a Overweight and lowers the price target from $120 to $85.

Barclays Maintains Overweight on Camtek, Lowers Price Target to $85

AMAT

ASML

AVGO

INDI

MPWR

QCOC

SLAB

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TSEM

Shares of semiconductor companies are trading lower after Huawei announced it's preparing AI chips as an alternative to Nvidia. Additionally, trade restrictions and tariff concerns are weighing on stocks in the industry.

B of A Securities analyst Vivek Arya maintains Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) with a Buy and lowers the price target from $105 to $80.

B of A Securities Maintains Buy on Camtek, Lowers Price Target to $80

AMKR

INTC

KLAC

MCHP

QCOM

Shares of chip stocks are trading lower after NVIDIA said it was recently informed by the US government that it will need a license to export chips to China. Additionally, warned that tariffs have increased uncertainty surrounding the company's outlook, which may be adding to the weakness across the board.

Comments

Camtek

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL